Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Kabir Nath | Chief Executive Officer | 2025-08-01 | 6,366 | $4.34 | $27.63kSell |
Teri Loxam | Chief Financial Officer | 2025-03-03 | 4,468 | $3.67 | $16.40kSell |
Kabir Nath | Chief Executive Officer | 2025-02-03 | 15,516 | $4.31 | $66.87kSell |
Life Sciences Nv Atai | 10% Owner | 2024-09-26 | 2,660,000 | $6.05 | $16.09MSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ekaterina Malievskaia | 11.04% | 10,592,171 | $54.44M | Insider |
George Jay Goldsmith | 11.02% | 10,576,167 | $54.36M | Insider |
Deep Track Capital LP | 9.20% | 8,831,007 | $45.39M | Institution |
Rtw Investments LP | 8.57% | 8,221,929 | $42.26M | Institution |
Life Sciences Nv Atai | 7.20% | 6,905,774 | $35.50M | Insider |
Nantahala Capital Management LLC | 4.36% | 4,179,930 | $21.48M | Institution |
Vivo Capital LLC | 3.50% | 3,362,385 | $17.28M | Institution |
Gmt Capital Corp | 1.86% | 1,781,718 | $9.16M | Institution |
Pfm Health Sciences LP | 1.85% | 1,779,259 | $9.15M | Institution |
Woodline Partners LP | 1.83% | 1,755,938 | $9.03M | Institution |